Keywords: Ras oncogene, Genentech, Roche

Inhibitors of infamous Ras oncogene reported by Genentech researchers

Article | 04 December 2011

Print This

A drug discovery team at Genentech, a subsidiary of Swiss drug major Roche (ROG: SIX) has uncovered a chink in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in